DIY looping keeps patients in target glucose range for longer: study
Researchers say open-source automated insulin delivery tech works well for both children and adults with type 1 diabetes
Kiwi research has shown the use of DIY automated insulin delivery could help patients with type 1 diabetes stay in their target glucose range for more hours of the day.
A study from the University of Otago, New Zealand, has put the original, patient-designed automated insulin delivery (AID) system, OpenAPS, to the test in a randomised controlled trial, finding it to be “safe and effective”.
